These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27665101)

  • 41. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
    Ghaswalla PK; Harpe SE; Slattum PW
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ATRIAL FIBRILLATION AND STROKE PREVENTION PRACTICES IN PATIENTS WITH CANDIDACY FOR ANTICOAGULATION THERAPY.
    Ullah I; Ahmad F; Ahmad S; Hayat Y
    J Ayub Med Coll Abbottabad; 2015; 27(3):669-72. PubMed ID: 26721036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
    Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
    Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-World Antithrombotic Therapy in Atrial Fibrillation Patients with a History of Percutaneous Coronary Intervention.
    Horiguchi A; Fukaya H; Oikawa J; Shirakawa Y; Kobayashi S; Arakawa Y; Nishinarita R; Nakamura H; Ishizue N; Igarashi G; Satoh A; Kishihara J; Niwano S; Ako J
    Int Heart J; 2019 Nov; 60(6):1321-1327. PubMed ID: 31735777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
    García-Honrubia A; Roldán V; Climent V; Sogorb F; Marín F
    Int J Cardiol; 2006 Jun; 110(2):271-2. PubMed ID: 16343666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.
    De Caterina R; Ammentorp B; Darius H; Le Heuzey JY; Renda G; Schilling RJ; Schliephacke T; Reimitz PE; Schmitt J; Schober C; Zamorano JL; Kirchhof P;
    Heart; 2014 Oct; 100(20):1625-35. PubMed ID: 25106421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.
    Dentali F; Douketis JD; Lim W; Crowther M
    Arch Intern Med; 2007 Jan; 167(2):117-24. PubMed ID: 17242311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Missed Opportunities to Initiate Oral Anticoagulant in Atrial Fibrillation: Insights from Australian Acute Coronary Syndrome Registries.
    Ma M; Hyun K; D'Souza M; Chew D; Brieger D
    Heart Lung Circ; 2021 Aug; 30(8):1157-1165. PubMed ID: 33642171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
    Lu W; Chen L; Wang Y; Yao Y; Fu C; Zuo P; Ma G
    Contemp Clin Trials; 2015 Jan; 40():166-71. PubMed ID: 25513965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
    Fox KAA; Velentgas P; Camm AJ; Bassand JP; Fitzmaurice DA; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Dabrowski E; Luo K; Gibbs L; Kakkar AK;
    JAMA Netw Open; 2020 Feb; 3(2):e200107. PubMed ID: 32101311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
    Lip GY; Karpha M
    Chest; 2006 Dec; 130(6):1823-7. PubMed ID: 17167003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atrial fibrillation and stroke prevention.
    Lip GY; Lim HS
    Lancet Neurol; 2007 Nov; 6(11):981-93. PubMed ID: 17945152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of atrial fibrillation comorbid with coronary heart disease].
    Takatsuki S
    Nihon Rinsho; 2013 Jan; 71(1):142-7. PubMed ID: 23631186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inappropriate combination of warfarin and aspirin.
    Turan B; Demir H; Mutlu A; Daşlı T; Erkol A; Erden İ
    Anatol J Cardiol; 2016 Mar; 16(3):189-96. PubMed ID: 26467380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
    Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
    Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
    Athanasakis K; Boubouchairopoulou N; Karampli E; Tarantilis F; Savvari P; Bilitou A; Kyriopoulos J
    Am J Cardiovasc Drugs; 2017 Apr; 17(2):123-133. PubMed ID: 27882517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.